LCM
GOSS icon

Laurion Capital Management’s Gossamer Bio GOSS Stock Holding History

Laurion Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,343,772
Closed -$1.65M – 325
2025
Q2 		$1.65M Sell
1,343,772
-207,656
-13% -$226K 0.03% 173
2025
Q1 		$1.71M Buy
1,551,428
+63,446
+4% +$73.3K 0.04% 153
2024
Q4 		$1.35M Hold
1,487,982
– – 0.02% 198
2024
Q3 		$1.47M Sell
1,487,982
-975,665
-40% -$939K 0.02% 172
2024
Q2 		$2.22M Buy
2,463,647
+162,796
+7% +$122K 0.03% 218
2024
Q1 		$2.72M Buy
+2,300,851
New +$2.53M 0.02% 316
2023
Q2 		– Sell
-56,960
Closed -$71.8K – 642
2023
Q1 		$71.8K Buy
+56,960
New +$109K ﹤0.01% 406
2019
Q2 		– Sell
-25,000
Closed -$542K – 997
2019
Q1 		$542K Buy
+25,000
New +$521K 0.01% 620

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Laurion Capital Management's GOSS Position: Q3 2025 in Review

Laurion Capital Management sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 1,343,772 shares — an estimated $1.65M sold.

Laurion Capital Management first reported a position in GOSS in Q1 2019 and held it in 8 quarters. The position peaked at $2.72M in Q1 2024. 164 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • Laurion Capital Management reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • Laurion Capital Management sold 1,343,772 Gossamer Bio shares in Q3 2025, an estimated $1.65M.
  • Laurion Capital Management first reported a position in Gossamer Bio in Q1 2019 and held it in 8 quarters.
  • Laurion Capital Management's Gossamer Bio position peaked at $2.72M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.